AI assistant
Sending…
X4 Pharmaceuticals, Inc — Director's Dealing 2019
Apr 27, 2019
34355_dirs_2019-04-26_6902b44d-e4e9-4e77-972b-c017b6eb0414.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2019-04-24
Reporting Person: Kelley Lynne E (See Remarks)
More from X4 Pharmaceuticals, Inc
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Mar 20
Regulatory Filings
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Annual Report
2026
Mar 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17